Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
JAMA
; 328(11): 1104-1107, 2022 09 20.
Article
in English
| MEDLINE | ID: covidwho-2047336
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Drug Resistance, Viral
/
Antibodies, Neutralizing
/
Antibodies, Monoclonal, Humanized
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Topics:
Variants
Limits:
Humans
Language:
English
Journal:
JAMA
Year:
2022
Document Type:
Article
Affiliation country:
Jama.2022.13854
Similar
MEDLINE
...
LILACS
LIS